loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Alisertib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Alisertib

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    1. Also known as: 1028486-01-2, Mln8237, Mln-8237, Mln 8237, Mln8237 (alisertib), 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid
    Molecular Formula
    C27H20ClFN4O4
    Molecular Weight
    518.9  g/mol
    InChI Key
    ZLHFILGSQDJULK-UHFFFAOYSA-N
    FDA UNII
    T66ES73M18
    Alisertib is a second-generation, orally bioavailable, highly selective small molecule inhibitor of the serine/threonine protein kinase Aurora A kinase with potential antineoplastic activity. Alisertib binds to and inhibits Aurora A kinase, which may result in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome segregation, and inhibition of cell proliferation. Aurora A kinase localizes to the spindle poles and to spindle microtubules during mitosis, and is thought to regulate spindle assembly. Aberrant expression of Aurora kinases occurs in a wide variety of cancers, including colon and breast cancers.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid
    2.1.2 InChI
    InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)
    2.1.3 InChI Key
    ZLHFILGSQDJULK-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC
    2.2 Other Identifiers
    2.2.1 UNII
    T66ES73M18
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Mln 8237

    2. Mln-8237

    3. Mln8237

    2.3.2 Depositor-Supplied Synonyms

    1. 1028486-01-2

    2. Mln8237

    3. Mln-8237

    4. Mln 8237

    5. Mln8237 (alisertib)

    6. 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic Acid

    7. Alisertib [usan]

    8. 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic Acid

    9. Chembl483158

    10. T66es73m18

    11. Alisertib (usan)

    12. 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic Acid

    13. 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic Acid

    14. Benzoic Acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-

    15. Alisertib [usan:inn]

    16. Unii-t66es73m18

    17. Mln8237,alisertib

    18. Kinome_3770

    19. Alisertib [inn]

    20. Alisertib; Mln8237

    21. Alisertib (mln8237)

    22. Mln8237 - Alisertib

    23. Alisertib [who-dd]

    24. Mls006011041

    25. Schembl855823

    26. Gtpl7790

    27. Dtxsid30145539

    28. Ex-a024

    29. Min8237

    30. Chebi:125628

    31. Hms3654e08

    32. Hms3673i07

    33. Hms3743e17

    34. Amy24201

    35. Bcp01823

    36. Bdbm50277545

    37. Mfcd16621243

    38. Nsc759677

    39. Nsc799329

    40. S1133

    41. Zinc40939534

    42. Akos015924647

    43. Bcp9000956

    44. Ccg-264832

    45. Cs-0106

    46. Db05220

    47. Mln 8237 (contain 10% Dmso)

    48. Nsc-759677

    49. Nsc-799329

    50. Sb16658

    51. Ncgc00263271-01

    52. Ncgc00263271-02

    53. Ncgc00263271-10

    54. 4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)-2-methoxybenzoic Acid

    55. Ac-25236

    56. As-17005

    57. Hy-10971

    58. Smr004702834

    59. Ft-0672433

    60. Sw219771-1

    61. D10085

    62. J-514220

    63. Brd-k75295174-001-03-5

    64. Q15633917

    65. 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxy Mln 8237 (contain 10% Dmso)

    66. 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-benzoic Acid

    67. 4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)-2-methoxybenzoic Acid

    68. 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl) -5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic Acid

    69. A5b

    2.4 Create Date
    2008-05-05
    3 Chemical and Physical Properties
    Molecular Weight 518.9 g/mol
    Molecular Formula C27H20ClFN4O4
    XLogP35
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count6
    Exact Mass518.1157110 g/mol
    Monoisotopic Mass518.1157110 g/mol
    Topological Polar Surface Area106 Ų
    Heavy Atom Count37
    Formal Charge0
    Complexity836
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    For the treatment of various forms of cancer.

    Post Enquiry
    POST ENQUIRY